I just used Adamas as an example. If they knew the
Post# of 30027
Take a look at Acadia where everything was rosy and now the stock tanked. At least Elto has a good safety profile that's well established. I don't know about gocovri, but you are right, companies usually don't try to buy up the comp in the biotech field unless they bet on a lame horse.
Acadia Hits 4-Year Low After CNN Reports Concerns on Key Drug
https://www.bloomberg.com/news/articles/2018-...n-key-drug